Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

<p><strong>Introduction:</strong><br /> Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. Most such biomarker studies ar...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit:	Shi, L, Westwood, S, Baird, A, Winchester, L, Dobricic, V, Kilpert, F, Hong, S, Franke, A, Hye, A, Ashton, N, Morgan, A, Bos, I, Vos, S, Buckley, N, Kate, M, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, E, Sleegers, K, Frisoni, G, Blin, O, Richardson, J, Bordet, R, Molinuevo, J, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Zetterberg, H, Baker, S, Morgan, B, Streffer, J, Visser, P, Bertram, L, Lovestone, S, Nevado-Holgado, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Elsevier 2019

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

Geahča maid